anemia-postoperative anemia-has been associated with delirium and reduced quality of life (Th ein et al., 2009) , as well as reduced physical performance.
Although packed red blood cell (PRBC) transfusions have been used to treat anemia and often provide life-saving treatment to critical patients, they have been shown to be associated with increased morbidity and mortality (O'Keeff e et al., 2010; Rubinstein et al., 2013; Shaw et al., 2013) . Evidence exists to support an association between blood transfusion and clinical complications, such as electrolyte imbalances, organ failure, fl uid overload, and predisposition to nosocomial infections, possibly due to cellular changes that occur during storage (Bennett-Guerrero et al., 2007; Wang, Sun, Solomon, Klein, & Natanson, 2012) ; these outcomes may be exacerbated in older adult patients with decreased physiologic reserve. To address these risks and decrease unnecessary transfusions, recent PRBC transfusion guidelines promote restrictive (i.e., a transfusion indicated with Hb level of 7 to 8 g/dL) versus liberal (i.e., a transfusion indicated with Hb level of 9 to 10 g/dL) transfusion strategies where possible (Carson et al., 2016) . To contribute to the understanding of the risks and benefi ts of transfusions, the purpose of the current study was to perform a systematic review of the current literature regarding PRBC transfusion indications, practices, and associated outcomes in the older adult population.
Hb level often triggers the decision to complete a PRBC transfusion, with specifi c thresholds being established (Brunskill et al., 2015) . Other reasons PRBC transfusions may be triggered are due to patient age and existing comorbidities (Brunskill et al., 2015) . PRBC transfusion thresholds are often lower for older adults compared to their younger counterparts, despite a lack of clinical evidence to support this practice (Ad et al., 2015) . Th is lack of evidence is a signifi cant gap in the literature, as older adults experienced >1 million hospitalizations in 2012, with the number of stays where a PRBC transfusion was required doubling between 1997 and 2011 (Pfunter, Wier, & Stocks, 2013; Weiss & Elixhauser, 2014) .
Compounding the issue, older adults are more at risk for PRBC transfusion-associated overload as they may have diffi culty tolerating even moderate volumes of fl uid due to comorbidities, such as cardiovascular disease (Ad et al., 2015; Brunskill et al., 2015) . Despite these increased risks and being more vulnerable to poor outcomes, previous studies have often combined older adults with their younger counterparts or excluded them from studies altogether. For example, a recent systematic review by Lelubre and Vincent (2013) evaluated the eff ects of PRBC transfusion on outcomes in critically ill patients, but included studies of all adult patients (19 or older). As older adults present a complex scenario for patient care and may experience different outcomes compared to younger patient populations, evidence to support use of current PRBC transfusion guidelines among this population must be evaluated.
METHOD
To evaluate the science surrounding PRBC transfusion among older adults, a comprehensive search in PubMed, CINAHL, and Embase was completed using the terms "blood transfusion" and "aged." Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were used to guide and address the quality of this review (Moher, Liberati, Tetzlaff , & Altman, 2009 ). To include the most current state of the science as it applies to clinical practice, the search was fi ltered for randomized controlled trials (RCTs) published within the past 5 years (January 1, 2011 to April 4, 2016 . After eliminating duplicates, a total of 535 abstracts were reviewed ( Figure) . To be included in this review, studies needed to involve participants 65 or older who were also undergoing procedures that involved either receiving or preventing PRBC transfusion, or evaluated outcomes associated with PRBC transfusions in any manner. Reference lists of relevant articles were also reviewed and one additional citation was accrued. Th e current authors reached consensus on all abstracts and reviewed full text for inclusion in the analysis. A total of 10 articles were found relevant to this review. Quality of studies was evaluated using the SQUIRE (Standards for Quality Improvement Reporting Excellence) guidelines (Ogrinc et al., 2015) ( Table A , available in the online version of this article). Values were assigned for each item response, with a possible total ranging from 0 to 40; higher scores indicated higher bias.
Quality of Studies
All studies were conducted outside of the United States, in Europe (Gregersen, Borris, & Damsgaard, 2015a,b; Gregersen, Damsgaard, & Boris, 2015; Greiff et al., 2012; Kiessling et al., 2012; Serrano-Trenas et al., 2011; van Boven et al., 2013) and Asia (Fan et al., 2014; Okazaki et al., 2013; Yu et al., 2012) . Four studies focused on cardiac surgery patients (Greiff et al., 2012; Kiessling et al., 2012; van Boven et al., 2013; Yu et al., 2012) ; fi ve focused on orthopedic surgery patients, specifically for hip surgery (Fan et al., 2014; Gregersen, Boris, et al., 2015a,b; Gregersen, Damsgaard, et al., 2015; Serrano-Trenas et al., 2011) ; and one focused on gastrointestinal surgery (Okazaki et al., 2013) . Due to the variety of interventions and outcomes evaluated, meta-analysis of the data was not conducted. Sample sizes ranged from 48 to 284 participants (mean = 128 participants), indicating modest but adequate samples across trials. Among the 10 studies evaluated, the average bias score was 13 (SD = 3.4, range = 8 to 19) of a possible 40 points, indicating overall low bias. Th e three greatest sources of bias among studies were the discussion of methods used to assess completeness and accuracy of data, details related to missing data, and discussion of costs and strategic trade-off s associated with the study.
RESULTS
A summary of the evidence examined is shown in Table B (available in the online version of this article).
Transfusion Prevention
Serrano-Trenas et al. (2011) evaluated the use of intravenous (IV) iron sucrose before hip fracture surgery in 200 patients. Th e investigators found that, compared to those in the control group, patients who received IV iron sucrose experienced a reduction in PRBC transfusion requirements (14% vs 46%, respectively; p = 0.004) and faster recovery of RBC indices. However, this fi nding only applied to patients with intracapsular fractures with an admission or baseline Hb level ≥12 g/dL. Th us, IV iron sucrose before hip fracture surgery for older adults with higher preoperative Hb levels may promote improved postoperative outcomes. Grieff et al. (2012) examined the use of tranexamic acid in PRBC transfusion prevention among 64 older adults undergoing combined aortic valve replacement and coronary artery bypass graft (CABG) surgery. Tranexamic acid is one of the most commonly used drugs for hemostasis in cardiac surgery, and was delivered as an IV bolus prior to surgery in the intervention group. Although not signifi cant, patients who received tranexamic acid experienced less blood loss compared with a saline placebo group (695 mL, interquartile range [IQR] = 470 to 1,590 mL vs 1,035 mL, IQR = 517 to 1,485 mL, p = 0.36). Patients who received tranexamic acid also received fewer PRBC units (3 units, IQR = 2 to 5 units vs 5 units, IQR = 3 to 7 units, p = 0.049). Although tranexamic acid did not signifi cantly reduce postoperative bleeding, it reduced the need for PRBC transfusion. Kiessling et al. (2012) PRBC transfusion requirements compared to bone wax, bone wax is not commonly used due to "embolic and wound healing problems" (Yu et al., 2012, p. 644) , thus limiting the generalizability of this work.
In their randomized trial, van Boven et al. (2013) examined the use of restrictive fl uid management, similar to restrictive versus liberal transfusion, in 60 patients older than 70 undergoing CABG to determine its eff ectiveness in protecting organ function and improving postoperative outcomes. Participants were randomized into three groups: minimal fl uid CABG (mCABG), off -pump CABG, and conventional CABG. mCABG is a technique that was developed to reduce hemodilution while off ering a blood preservation eff ect. Among participants, 65% of the conventional CABG, 30% of the off -pump CABG, and 20% of the mCABG group required PRBC transfusion, with this group trending toward using less platelets and fresh frozen plasma products. Th e authors concluded that the fl uid restriction during mCABG contributed to the maintenance of physiological balances perioperatively, as well as the improved ventilation times and decreased blood product consumption postoperatively.
Transfusion-Associated Outcomes
Fan et al.'s (2014) trial evaluated development of postoperative delirium in 186 older adults undergoing elective unilateral hip replacement with use of spinal anesthesia.
Participants were randomized to either a restrictive transfusion strategy (Hb < 8.0 g/dL) or a liberal transfusion strategy (Hb < 10.0 g/dL). Investigators evaluated patients using the Confusion Assessment Method for the intensive care unit and found no diff erence in development of delirium based on transfusion strategy (21.3% for the transfusion strategy group vs 23.9% for the liberal transfusion strategy group, p > 0.05). Th ey concluded that a restrictive transfusion strategy was safe and eff ective among older adults undergoing hip replacement surgery, and did not increase the risk of postoperative delirium.
As part of the Transfusion Requirements in Frail Elderly (TRIFE) RCT, Gregersen, Borris, et al. (2015b) examined how PRBC transfusion strategies (restrictive vs liberal) impact physical recovery from disabilities and mortality. In the study, 284 frail adults 65 and older with hip fracture were assigned to the restrictive group (Hb <9.7 g/dL; <6 mmol/L) or liberal group (Hb <11.3 g/dL; <7 mmol/L) for PRBC transfusions within the fi rst 30 days postoperatively. Investigators found no signifi cant diff erences in measures of activities of daily living between groups. For those older adults residing in a nursing home, 30-day mortality was higher in the restrictive group (hazard ratio [HR] = 2.4, 95% confi dence interval [CI] [1.1, 5.2]; p = 0.03), as was 90-day mortality (36% in restrictive group vs 20% in liberal group, HR = 2.0, 95% CI [1.1, 3.6]; p = 0.01). Gregersen, Borris, et al. (2015a) conducted a second study from the TRIFE RCT examining the impact of restrictive versus liberal PRBC transfusion strategy on quality of life, depression, and activities of daily living for frail older adults with hip fracture. A total of 157 nursing home residents 65 and older with a Mini-Mental State Examination score ≥5 were assigned to either the restrictive group (Hb <9.7 g/dL; <6 mmol/L) or liberal group (Hb <11.3 g/dL; <7 mmol/L) for PRBC transfusions within the fi rst 30 days postoperatively. Quality of life and depression scores were similar for both groups at 30-day and 1-year follow up. In the restrictive group, the median activities of daily living score, which was measured by the modifi ed Barthel Index and ranged from 0 to 100 (100 = best), at 1-year post-surgery was 76 (IQR = 48 to 86), which represented a sum-score increase of 9.18 points from day 30 until 1 year post-surgery. For the liberal transfusion group, the median activities of daily living score was 78 (IQR = 61 to 86) at 1 year postsurgery, with the sum-score increasing by 16 points from day 30 to 1 year post-surgery. Th e diff erence in the liberal transfusion group was statistically greater than that in the restrictive group (95% CI [0.41, 13.3]; p = 0.03), indicating a better recovery of mobility and physical functioning for the liberal transfusion group.
Using data from the TRIFE RCT, Gregersen, Damsgaard, et al. (2015) compared the association between a liberal or restrictive PRBC transfusion strategy and risk of infection for frail older adults after unilateral hip surgery. Th e Comprehensive Geriatric Assessment Frailty Index was used to measure level of frailty and equality level of frailty between groups. Of 227 adults 65 and older, 72% of patients in the restrictive transfusion group developed an infection compared to 66% of those in the liberal group (risk ratio [RR] = 1.08; 95% CI [0.93, 1.27]; p = 0.29). Investigators concluded that a more Administering intravenous iron sucrose, tranexamic acid, bone wax, and fl uid restriction during surgery may decrease the need for packed red blood cell transfusion in older adults.
liberal transfusion strategy was not associated with a higher risk of infection for this group of patients. Conversely, Okazaki et al. (2013) found in their RCT examining 48 older adults (age >70) undergoing gastroenterological surgery that the use of perioperative blood transfusion was an independent risk factor for infectious complications (odds ratio [OR] = 6.476, 95% CI [1. 179, 35 .58]; p = 0.032). In this study, perioperative blood transfusion was defi ned as including the transfusion of PRBCs preoperatively, intraoperatively, and up to 48 hours postoperatively. Th e diff erence in the fi ndings of these two studies could be attributed to the difference in patient populations.
DISCUSSION
Th e current analysis revealed 10 investigations of methods to prevent PRBC transfusion or outcomes associated with PRBC transfusion in the older adult population. Among these, fi ve studies (50%) focused on interventions to prevent blood loss or PRBC transfusion, and the remaining fi ve focused on outcomes associated with PRBC transfusion. All studies focused on one of three surgical populations, including cardiac, orthopedic, and gastrointestinal.
Findings among PRBC transfusion prevention studies were mixed and may not represent methods commonly used in Western medicine. Although more research is required, promising techniques for PRBC transfusion prevention were highlighted. Administering IV iron sucrose, tranexamic acid, bone wax, and fl uid restriction during surgery may help decrease the need for PRBC transfusion in older adults.
Findings were also inconclusive about outcomes following PRBC transfusion. Restrictive PRBC transfusion was found to be a safe and eff ective treatment in one study (Fan et al., 2014) , but others found a more liberal PRBC transfusion strategy to be benefi cial in promoting recovery and physical functioning postoperatively (Gregersen, Borris, et al., 2015a) , and decreasing mortality (Gregersen, Borris, et al., 2015b) .
Collectively, these fi ndings indicate a wide range of interventions and outcomes evaluated, with little consistency in methodology and overall inconclusive results. Th e inconsistency could be a result of the limitation regarding the lack of distinction between the groups of older adults. For frail older adults, the benefi ts of a more liberal PRBC transfusion strategy could outweigh the risks. Older adults present a particularly challenging population for PRBC transfusion research due to several factors. Due to the aging process, older adults commonly experience multiple comorbidities and an extensive health history. Th ese issues may result in a limited degree of physical resilience that can impact their need for transfusion and physiological reserve (Nakamura et al., 2015) . Older adults are generally excluded from transfusion research due to the added complexity of their care. Exceptions to this exclusion can be found, such as the studies in the current review that included the areas of gastrointestinal, orthopedic, and cardiac surgery. To help address the heterogeneity of the older adult population, more research is needed to examine the unique needs of older adults as they continue to age, as well as the role of comorbidities and frailty on PRBC transfusion prevention and outcomes.
Another issue that could have contributed to the inconsistent fi ndings in the current review is the length of storage time for the PRBCs. A primary source of concern with PRBC transfusion is the eff ect of the storage lesion, or stored PRBC toxicity, on patient outcomes. Per federal guidelines, PRBCs may be stored for a maximum of 42 days (American Association of Blood Banks, 2013). However, during this time, cells experience a change in their overall structure that results in an inability to transport oxygen once transfused, and potential breakdown of the cell membrane that allows release of intracellular contents (Orlov & Karkouti, 2015) . Th ese changes worsen with increased storage duration and may result in a stored PRBC toxicity in the transfused patient (Orlov & Karkouti, 2015) . Th us, patients with decreased physiologic reserve, such as older adults with multiple comorbidities, may be more prone to the eff ects of the storage lesion when transfused.
Recent fi ndings of an international, randomized trial (N = 20,858) revealed no diff erence in in-hospital mortality rate among adults 18 or older who received either the freshest or oldest PRBCs available . However, investigators did not control for patient age in their analyses, collect data on patient comorbidities, or indicate the reason for PRBC transfusion other than a primary admitting diagnosis category (e.g., cardiovascular disease, cancer). Th e mechanisms by which stored PRBC toxicity impacts patient outcomes have yet to be fully elucidated, and the eff ect of stored PRBC age on patient outcomes remains controversial. PRBC age was not controlled for in the studies reviewed, and thus may provide additional insight regarding the fi ndings. Studies examining the length of storage duration and its impact on the outcomes for older adults are needed to determine the maximum storage duration for safely transfusing this population.
Other factors that potentially infl uence PRBC transfusion requirements and outcomes include biases and physiological factors related to patient gender and ethnicity. In a post-hoc analysis of >6,500 patients who underwent CABG or orthopedic surgery (total hip or total knee replacement), investigators reported a signifi cantly higher transfusion rate in women compared to men across all types of surgery (CABG: 81% vs 49%, total hip: 46% vs 24%, total knee: 37% vs 23%; p < 0.0001) despite similar median age (mean age for women = 70 years [IQR = 56 to 84 years], mean age for men = 67 years [IQR = 53 to 81 years]) (Gombotz, Schreier, Neubauer, Kastner, & Hofmann, 2016) . Women also received transfusions of one or two PRBCs more often than men, although investigators noted that this might be the result of women more often experiencing higher levels of anemia rather than a bias in care delivery (Gombotz et al., 2016) .
In a secondary analysis of a nationwide sample, Qian et al. (2014) examined racial disparities in the use of perioperative blood transfusion among patients undergoing major surgery, including CABG (n = 25,849), total hip replacement (n = 42,933), and isolated colectomy (n = 8,255) in 87 hospitals. Median age of patients was similar across surgery types, ranging from 57 to 65 years. After controlling for patient age, gender, admission status, severity of illness, and comorbidities, Black patients were more likely than White patients to receive one or more units of PRBCs during CABG (OR = 1.41, 95% CI [1.13, 1.76], p = 0.002) and total hip replacement (OR = 1.39, 95% CI [1.20, 1.62], p < 0.001) (Qian et al., 2014) . Th us, biases in care delivery and diff erences in physiological response to hemorrhage and PRBC transfusion should be considered in the older adult population.
Evidence indicates that anemia in older adults adversely aff ects their morbidity and mortality, which may be especially true when surgery is required (Vochteloo et al., 2011) . When comparing liberal and restrictive transfusion therapies for patients 60 and older undergoing cardiac surgery, Nakamura et al. (2015) found that the cardiovascular risk posed by anemia was more harmful than the risks associated with PRBC transfusion. Risks from PRBC transfusion include increased infection rates, acute hemolytic and nonhemolytic reactions, and transfusion-associated circulatory overload (Nakamura et al., 2015; Vochteloo et al., 2011) .
Despite these risks from PRBC transfusion, the risks from anemia (e.g., cardiogenic shock, increased intensive care unit and hospital stay) were greater for patients undergoing cardiac surgery (Nakamura et al., 2015) . Adding to the evidence of risks of anemia, a retrospective study examining outcomes for 1,262 older adult patients with hip fracture who were treated surgically found that mortality rate, delirium incidence, and discharge rates to a nursing home were signifi cantly worse for those experiencing anemia preoperatively (Vochteloo et al., 2011) . Th e study also showed that postoperative anemia was an independent risk factor for worse outcomes for hip fracture patients (Vochteloo et al., 2011) .
LIMITATIONS
It could be argued that older adults undergoing preplanned surgeries or interventions may be more physiologically stable than older adults who have experienced a trauma and, as such, the fi ndings from the current review may be limited and must be interpreted with caution. Inclusion of only those patients physiologically stable enough to endure major procedures introduces a source of bias and should be considered in the interpretation of the fi ndings. In addition to the limited generalization, three of 10 studies originated from the same parent study, which could contribute to selection bias and put too much emphasis on the fi ndings from those studies. Having a cutoff age of 65 or older may have eliminated studies that had applicable fi ndings that would have contributed to the current conclusions.
Another limitation of this review was the lack of stratifi cation of the age groups for those 65 and older. An individual who is 85 years old may face diff erent risks and health concerns compared to one who is 65 years old. Due to the small sample of relevant articles, all individuals 65 and older were considered as one group. In future studies, it would be helpful to examine the potential diff erences facing older adults in diff erent age groups to highlight potential distinctions so they may be factored into PRBC guidelines.
FUTURE RESEARCH
To assist with clinical decision making, more RCTs are needed that examine the clinical outcomes for older adults receiving PRBC transfusions, including mortality, infection rates, functional ability, and quality of life. More defi nitive conclusions are needed regarding the risks and benefi ts for this potentially vulnerable patient population. Future studies should examine the diff erences between older adults and their younger counterparts when receiving PRBCs. Another area that shows promise is restrictive PRBC transfusions. However, results have been mixed and it remains to be determined whether the benefi ts of restrictive transfusions outweigh the risks anemia poses for older adults.
One area of interest that continues to grow is the concept of patient blood management (PBM). PBM is defi ned by the Society for the Advancement of Blood Management (2017) as "the timely application of evidencebased medical and surgical concepts designed to maintain hemoglobin concentration, optimize hemostasis and minimize blood loss in an eff ort to improve patient outcome." PBM bundles are available to promote implementation of these methods in the clinical setting, and include topics that range from PBM program development and inclusion of stakeholders to management of anemia and coagulopathy, and methods of benchmarking patient outcomes (Meybohm et al., 2017) .
IMPLICATIONS FOR CLINICAL PRACTICE
Th e older adult population continues to grow; thus, clinicians who care for them must be aware of the risks and benefi ts of current treatment practices. Blood transfusions are commonly used to treat anemia in older adults due to a variety of conditions and in multiple settings aside from the perioperative arena. Current blood transfusion guidelines set by the American Association of Blood Banks (2013) do not include indications for frail and/or older adult patients. Older adults regularly experience multiple comorbidities and decreased physiologic resilience, meaning they may require additional monitoring during and after PRBC transfusions to prevent complications. Advance practice providers should consider the traditional transfusion indications of lab values and vital signs in the older adult population, as well as the individual needs of the patient with regard to their tolerance of blood transfusion and its potential consequences. In addition, advanced practice nurses prescribing these treatments should carefully consider potential alternatives to transfusion, if possible. Such considerations may maximize patient outcomes and decrease use of health care resources or provide a more costeff ective method for treatment.
CONCLUSION
Evidence of the best practices for PRBC transfusions for the older adult surgical population remains inconclusive and contradictory. To optimize care for older adults, continued study of the indications and outcomes of PRBC transfusions and development of protocols to address their unique requirements are needed. Indicates the manuscript concerns an initiative to improve healthcare Yes ( 11 IV = intravenous; PRBC = packed red blood cells; CABG = coronary artery bypass graft; IQR = interquartile range; ICU = intensive care unit; OR = odds ratio; CI = confidence interval; mCABG = minimal fluid coronary artery bypass graft; opCAB = off-pump coronary artery bypass; cCABG = conventional coronary artery bypass graft; Hb = hemoglobin; QOL = quality of life; ADL = activities of daily living; HR = hazard ratio; RR = risk ratio.
